Stress protein-induced immunosuppression: Inhibition of cellular immune effector functions following overexpression of haem oxygenase (HSP 32)

Transplant Immunology

Volumn 6, Issue 2, 1998, Pages 84-93

  Woo, Jacky ^a   Iyer, Suhasini ^a   Cornejo, Marie Christine ^a   Mori, Nancy ^a   Gao, Lan ^a   Sipos, Isabelle ^a   Maines, Mahin ^b   Buelow, Roland ^a  

^a GENZYME CORPORATION   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYANOCOBALAMIN; GAMMA INTERFERON; HEAT SHOCK PROTEIN; HEME OXYGENASE; INTERLEUKIN 10; INTERLEUKIN 2; PROTOPORPHYRIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELLULAR IMMUNITY; CYTOTOXIC T LYMPHOCYTE; GROWTH INHIBITION; IMMUNE DEFICIENCY; KIDNEY; LIVER; MALE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; SPLEEN;

EID: 0031712370     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0966-3274(98)80022-1     Document Type: Article

References (54)

1. Lindquist S, Craig SA. The heat-shock proteins. Annu Rev Genet. 22:1988;631-677.
2. Ellis RJ, de Vries SMV. Molecular chaperones. Annu Rev Biochem. 60:1991;321-347.
3. Georgopoulos C, Welch WJ. Role of major heat shock proteins as molecular chaperons. Annu Rev Cell Biol. 3:1993;601-634.
4. Kaufmann SHE, Shoel B. Heat shock proteins as antigens in immunity against infection and self. Morimoto RI, Tissicres A, Georgopoulos C. The biology of heat shock proteins and molecular chaperones. 1994;495-501 Cold Spring Harbor Laboratory, New York.
5. Hermann E, Lohse AW, Mayer WJ, et al. Stimulation of synovial fluid mononuelear cells with the human 65-kd heat shock protein or with live enterobacteria leads to preferential expansion of TCR-gd+ lymphocytes. Clin Exp Immunol. 89:1992;427-433.
6. Salvetti M, Buttinelli G, Ristori M, et al. T-lymphocyte reactivity to the recombinant mycobacterial 65 and 70 kDa heat shock proteins in multiple sclerosis. J Autoimmunol. 5:1992;691-702.
7. Elias D, Markovits D, Reshef T, van der Zee R, Cohen IR. Induction and therapy of autoimmune diabetes in non-obese diabetic (NOD/Lt) mouse by a 65 kDa heat shock protein. Proc Natl Acad Sci USA. 87:1990;1576-1580.
8. Polla B, Mariethoz E. More evidence for a case of chaperones in antigen processing. Immunol Today. 13:1992;421-422.
9. De Nagel DC, Pierce SK. Heat shock proteins in immune responses. Crit Rev Immunol. 13:1993;71-81.
10. Manara GC, Sansoni P, BadialideGiorgi L, et al. New insights suggesting a possible role of heat shock protein 70-kD family-related protein in antigen processing/presentation phenomenon in humans. Blood. 82:1993;2865-2871.
11. William DB, Watts TH. Molecular chaperones in antigen presentation. Curr Biol Immunol. 7:1995;77-84.
12. Perdrizet GA. The heat shock response and organ transplantation. Transplantation Rev. 10:1996;78-98.
13. Hutchinson KA, Dittmar KD, Pratt WB. All of the factors required for assembly of the glucocortoid receptor into a functional heterocomplex with heat shock protein 90 are preassociated in a self-sufficient protein folding structure, a 'foldosome'. J Biol Chem. 269:1994;27894-27899.
14. Maines MD. Heme oxygenase: clinical applications and functions. 1992;266-294 CRC Press, Boca Raton, FL.
15. Maines MD, Trakshel GM, Kutty RK. Characterization of two constitutive forms of rat liver microsomal heme oxygenase: only one molecular species of the enzyme is inducible. J Biol Chem. 261:1986;411-419.
16. Trakshiel GM, Kutty RK, Maines MD. Purification and characterization of the major constitutive form of testicular heme oxygenase: the non-inducible isoform. J Biol Chem. 261:1986;11131-11137.
17. Willis D, Moore AR, Frederick R, Willoughby DA. Heme oxygenase: a novel target for the modulation of the inflammatory response. Nature Med. 2:1996;87-90.
18. Agarwal A, Kim Y, Matas AJ, Alam J, Nath KA. Gas-generating systems in acute renal allograft rejection in the rat. Transplantation. 6:1996;93-98.
19. Cantoni L, Rossi C, Rizzardini M, Massimo G, Ghezzi P. Interleukin-1 and tumour necrosis factor induce hepatic hemeoxygenase: feedback regulation by glucocorticoids. J Biochem. 279:1991;891-894.
20. Mitani K, Fijita H, Kappas A, Sassa S. Hemeoxygenase is a positive acute-phase reactant in human Hep3B hepatoma cells. Blood. 79:1992;1255-1259.
21. Lee PJ, Alam J, Wiegand GW, Choi AMK. Overexpression of heme oxygenase-1 in human pulmonary epithelial cells results in growth arrest and increased resistance to hyperopia. Proc Natl Acad Sci USA. 93:1996;10393-10398.
22. Maines MD, Kappas A. Cobalt stimulation of heme degradation in the liver. Dissociation of microsomal heme degradation from cytochrome P450. J Biol Chem. 250:1975;4171-4177.
23. Maines MD. New developments in the regulation of heme metabolism and their implications. CRC Crit Rev Toxicol. 12:1984;241-314.
24. Alam J, Zhining D. Distal AP-1 binding sites mediate basal level enhancement and TPA induction of the mouse hemeoxygenase-1 gene. J Biol Chem. 267:1992;21894-21900.
25. Rosenberg DW, Drununond DS, Kappas A. The influence of organometals on heme metabolism. In vitro and in vivo studies with organotins. Mol Pharmacol. 21:1982;150-158.
26. Maines MD. Zinc protoporphyrin is a selective inhibitor of heme oxygenase activity in the neonatal rat. Biochem Biophys Acta. 673:1981;339-350.
27. Drummond GS, Kappa A. Prevention of neonatal hyperbilirubinemia by tin protoporphyrin IX, a potent competitive inhibitor of heme oxidation. Proc Natl Acad Sci USA. 78:1981;6466-6470.
28. Vreman HJ, Cipkala DA, Stevenson DK. Characterization of porphyrine heme oxygenase inhibitors. Can J Physiol Pharmacol. 74:1996;278-285.
29. Frydman RB, Tomaro ML, Buldain G, Awruch J, Diaz L, Frydman B. Specificity of heme oxygenase: a study with synthetic hemins. Biochem. 20:1981;5177-5182.
30. Kutty RK, Maines MD. Purification and characterization of biliverdin reductase from the rat liver. J Biol Chem. 256:1981;3956-3962.
31. Hillmann G, Beyer G. Rapid diazo method for determination of total bilirubin with a mixed reagent. Z Klin Chem. 5:1967;92-93.
32. Coligan JE, Kruisbeek AM, Margulies DH, Shevach EM, Strober W eds. Current protocols in immunology. New York: Green Publishing and Wiley-Interscience: 5.7.1-5.7.6.
33. Shen-Tanner XF, Miller RG. Correlation between lymphocyte-induced donor-specific tolerance and donor cell recirculation. Transplantation. 57:1994;1081-1087.
34. Ono K, Lindsey ES. Improved technique of heart transplantation in rats. J Thorac Cardiovasc Surg. 57:1969;225-229.
35. Yamaguchi T, Terakado M, Horio F, Kazuma A, Tanaka M, Nakajima H. Role of bilirubin as an anti-oxidation in an ischaemia-reperfusion of rat liver and induction of heme oxygenase. Biochem Biophys Res Com. 233:1996;129-135.
36. Stocker R, Yamamoto Y, McDonagh AF, Glazer AN, Ames BN. Bilirubin is an antioxidant of possible physiological importance. Science. 235:1987;1043-1046.
37. Neuzil J, Stocker R. Free and albumin-bound bilirubin are efficient anti-oxidants for α-tocopherol, inhibiting plasma and low density lipoprotein peroxidation. J Biol Chem. 261:1994;411-419.
38. Iyer S, Woo J, Comejo MC, Gao L, McCoubrey W, Maines MD, Buelow R. Characterization and bilogical significance of immuno-suppressive peptide D2702.75-84(E V) binding protein: isolation of heme oxygenase. J Biol Chem. 273:1998;2692-2697.
39. Maines MD. The heme oxygenase system: a regulator of second messenger gases. Annu Rev Pharmacol Toxicol. 37:1997;517-554.
40. Nakagami T, Toyomura K, Kinoshita T, Morisawa S. A beneficial role of bile pigments as an endogeneous tissue protector: anti-complement effects of biliverdin and conjugated bilirubin. Biochem Biophys Acta. 1158:1993;189-193.
41. Pratt JR, Hibbs MJ, Laver AJ, Smith RAG, Sacks SH. Allograft immune response with sCR1 intervention. Transplant Immunol. 4:1996;72-75.
42. Haga Y, Tempero AM, Kay D, Zetterman RK. Intracellular accumulation of unconjugated bilirubin inhibits phytohemagglutinin-induced proliferation and interleukin-2 production of human lymphocytes. Digestive Dis Sci. 41:1996;1468-1474.
43. Haga Y, Tempero MA, Zetterman RK. Unconjugated bilirubin inhibits in vitro major histocompatibility complex-unrestricted cytotoxicity in human lymphocytes. Biochem Biophys Acta. 1316:1996;29-34.
44. Sano K, Nakamura H, Matsuo T. Mode of inhibitory action of bilirubin on protein kinase C. Pediatr Res. 19:1985;587-590.
45. Kwak JY, Takeshiege K, Cheung BS, Minakami S. Bilirubin inhibits the activation of superoxide-producing NADPH oxidase in a neutrophil ce411-free system. Biochim Biophys Acta. 1076:1991;369-373.
46. Haga Y, Kay D, Tempero MA, Zetterman RK. Flow cytometric measurement of intracellular bilirubin in human peripheral blood mononuclear cells exposed to unconjugated bilirubin. Clin Biochem. 25:1992;277-283.
47. Briine B, Ulrich V. Inhibition of platelet aggregation by carbon monoxide is mediated by activation of guanylate cyclase. Mol Pharmacol. 32:1987;497-504.
48. Verma A, Hirsch DJ, Glatt CE, Ronnett RV, Synder SH. Carbon monoxide: a putative neural messenger. Science. 259:1993;381-384.
49. Diaz JA, Vara E, Garcia C, Villa N, Balibrea JL. Evidence for a cyclic guanosine monophosphate-dependent, carbon monoxide-mediated, signaling system in the regulation of TNF-α production by human pulmonary machrophages. Arch Surg. 130:1995;1287-1293.
50. Vaandrager AB, de Jonge HR. Signalling by cGMP-dependent protein kinase. Mol Cell Biochem. 157:1996;23-30.
51. Lincoln TM, Komalavilas P, Boerth NJ, MacMillan-Crow LA, Cornwell TL. cGMP signalling through cAMP- and cGMP-dependent protein kinases. Adv Pharmacol. 34:1995;305-322.
52. Finn JT, Grunwald ME, Yau KW. Cyclic nucleotide-gated ion channels: an extended family with diverse functions. Annu Rev Physiol. 58:1996;395-426.
53. Degerman E, Belfrage P, Manganiello VC. cGMP-inhibited phosphodiesterases (PDE gene family). Biochem Soc Trans. 24:1996;1010-1014.
54. Palacios JM, Beleta J, Segarra V. Second messenger systems as targets for new therapeutic agents: focus on selective phosphodiesterase inhibitors. Farmaco. 50:1994;819-827.